Utah Medical Products, Inc. (UTMD)

Utah Medical Products Balance Sheet

Financials in millions USD. Fiscal year is January - December.

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021
Cash & Equivalents	85.76	82.98	92.87	75.05	60.97
Cash & Short-Term Investments	85.76	82.98	92.87	75.05	60.97
Cash Growth	3.35%	-10.65%	23.74%	23.09%	18.19%
Accounts Receivable	3.52	4.09	3.39	5.54	5.13
Inventory	7.94	8.81	9.58	8.81	6.6
Other Current Assets	0.53	0.45	0.43	0.52	0.46
Total Current Assets	97.74	96.33	106.27	89.92	73.16
Net Property, Plant & Equipment	9.91	9.76	10.55	10.22	10.62
Other Intangible Assets	-	2.87	4.95	10.38	17.76
Goodwill	-	13.58	13.69	13.35	14.1
Total Assets	122.54	122.54	135.46	123.87	115.64
Accounts Payable	0.91	0.7	0.77	1.22	0.76
Accrued Expenses	1.69	3.06	3.94	4.74	2.98
Total Current Liabilities	2.6	3.76	4.71	5.96	3.75
Long-Term Leases	0.23	0.28	0.3	0.34	0.4
Other Long-Term Liabilities	0.45	1.07	2.14	3.32	4.36
Total Long-Term Liabilities	0.68	1.35	2.44	3.66	4.75
Total Liabilities	3.27	5.11	7.15	9.62	8.5
Common Stock	-	0.03	0.04	0.04	0.04
Additional Paid-in Capital	-	-	0.59	0.25	0.84
Accumulated Other Comprehensive Income	-	-11.91	-10.66	-12.04	-9.05
Retained Earnings	-	129.3	138.34	126.01	115.31
Shareholders' Equity	-	117.43	128.31	114.25	107.14
Total Liabilities & Equity	122.54	122.54	135.46	123.87	115.64
Total Debt	0.23	0.28	0.3	0.34	0.4
Net Cash (Debt)	85.53	82.69	92.57	74.71	60.58
Net Cash Growth	3.43%	-10.67%	23.91%	23.33%	18.19%
Net Cash Per Share	26.40	23.61	25.45	20.51	16.55
Book Value	0	117.43	128.31	114.25	107.14
Book Value Per Share	-	33.52	35.28	31.36	29.27
Tangible Book Value	0	100.98	109.68	90.52	75.28
Tangible Book Value Per Share	-	28.83	30.16	24.85	20.57

Updated Dec 31, 2025. Data Source: Fiscal.ai. Standard template. Financial Sources.

SEC Filings: 10-K · 10-Q